Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer.

Chu-Kuang Chou, Sam Li-Sheng Chen, Amy Ming-Fang Yen, Sherry Yueh-Hsia Chiu, Jean Ching-Yuan Fann, Han-Mo Chiu, Shu-Lin Chuang, Tsung-Hsien Chiang, Ming-Shiang Wu, Chien-Yuan Wu, Shu-Li Chia, Yi-Chia Lee, Shu-Ti Chiou, Hsiu-Hsi Chen
Author Information
  1. Chu-Kuang Chou: Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  2. Sam Li-Sheng Chen: School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
  3. Amy Ming-Fang Yen: School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
  4. Sherry Yueh-Hsia Chiu: Department and Graduate Institute of Health Care Management, Chang Gung University, Tao-Yuan, Taiwan.
  5. Jean Ching-Yuan Fann: Department of Health Industry Management, Kainan University, Tao-Yuan, Taiwan.
  6. Han-Mo Chiu: Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  7. Shu-Lin Chuang: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
  8. Tsung-Hsien Chiang: Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  9. Ming-Shiang Wu: Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  10. Chien-Yuan Wu: Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan.
  11. Shu-Li Chia: Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan.
  12. Yi-Chia Lee: Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  13. Shu-Ti Chiou: Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan.
  14. Hsiu-Hsi Chen: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Abstract

BACKGROUND: Outreach (i.e., to invite those who do not use, or who under use screening services) and inreach (i.e., to invite an existing population who have already accessed the medical system) approaches may influence people to increase their use of screening test; however, whether their outcomes would be equivalent remains unclear.
METHODS: A total of 3,363,896 subjects, 50-69 years of age, participated in a colorectal cancer (CRC) screening program using biennial fecal immunochemical tests; 34.5% participated during 2004-2009 when the outreach approach alone was used, and 65.5% participated from 2010-2013 when outreach was integrated with an inreach approach. We compared the outcomes of the two approaches in delivery of screening services.
RESULTS: Coverage rates increased from 21.4% to 36.9% and the positivity rate increased from 4.0% to 7.9%, while referral for confirmatory diagnostic examinations declined from 80.0% to 53.3%. The first period detected CRC in 0.20% of subjects screened, with a positive predictive value (PPV) of 6.1%, and the second detected CRC in 0.34% of subjects, with a PPV of 8.0%. After adjusting for confounders, differences were observed in the PPV for CRC (adjusted relative risk, 1.50; 95% confidence interval [CI], 1.41-1.60), cancer detection rate (1.20; 95% CI, 1.13-1.27), and interval cancer rate (0.72; 95% CI, 0.65-0.80). When we focused on the comparison between two approaches during the same study period of 2010-2013, the positivity rate of fecal testing (8.2% vs. 7.6%) and the PPV for CRC detection remained higher (1.07; 95% CI, 1.01-1.12) in subjects who were recruited from the inreach approach.
CONCLUSIONS: Outcomes of screening were equivalent or better after integration of outreach and inreach approaches.
IMPACT: The results will encourage makers of health-care policy to adopt the integration approach to deliver screening services.

References

  1. Gut. 2012 Jan;61(1):101-7 [PMID: 21561880]
  2. Ann Intern Med. 2014 Oct 21;161(8):537-45 [PMID: 25329201]
  3. Cochrane Database Syst Rev. 2013;2:CD001865 [PMID: 23450534]
  4. Am J Health Promot. 2012 May-Jun;26(5):295-300 [PMID: 22548424]
  5. Cancer Res Treat. 2010 Dec;42(4):191-8 [PMID: 21253320]
  6. N Engl J Med. 2013 Sep 19;369(12):1106-14 [PMID: 24047060]
  7. Gac Sanit. 2012 May-Jun;26(3):217-22 [PMID: 22361637]
  8. N Engl J Med. 2012 Feb 23;366(8):697-706 [PMID: 22356323]
  9. CMAJ. 2011 Sep 20;183(13):1474-81 [PMID: 21810951]
  10. Clin Gastroenterol Hepatol. 2009 Jul;7(7):770-5; quiz 711 [PMID: 19268269]
  11. Prev Med. 2014 May;62:132-41 [PMID: 24530610]
  12. Curr Oncol. 2013 Oct;20(5):252-7 [PMID: 24155629]
  13. Gastrointest Endosc. 2011 Mar;73(3):429-34 [PMID: 21353839]
  14. BMJ. 2014;348:g2467 [PMID: 24922745]
  15. Cancer. 2015 Sep 15;121(18):3221-9 [PMID: 25995082]
  16. Gastroenterology. 2014 Dec;147(6):1317-26 [PMID: 25200099]
  17. Int J Cancer. 2012 Jun 15;130(12):2961-73 [PMID: 21792895]
  18. Arch Intern Med. 2012 Apr 9;172(7):575-82 [PMID: 22493463]
  19. Gut. 2015 May;64(5):784-90 [PMID: 25179811]
  20. Cancer Epidemiol. 2013 Dec;37(6):959-67 [PMID: 24035240]
  21. Jpn J Clin Oncol. 2010 Oct;40(10):897-904 [PMID: 20495192]
  22. Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):453-9 [PMID: 10350442]
  23. Cancer. 2013 Aug 1;119 Suppl 15:2914-25 [PMID: 23868486]
  24. N Engl J Med. 2012 Jun 21;366(25):2345-57 [PMID: 22612596]
  25. J Gastroenterol Hepatol. 2012 Jun;27(6):1070-7 [PMID: 22004224]
  26. Ann Intern Med. 2014 Feb 4;160(3):171 [PMID: 24658694]
  27. J Med Screen. 2011;18(1):18-23 [PMID: 21536812]
  28. Prev Chronic Dis. 2012;9:E77 [PMID: 22482136]
  29. MMWR Morb Mortal Wkly Rep. 2013 Nov 8;62(44):881-8 [PMID: 24196665]
  30. J Health Care Poor Underserved. 2011 Aug;22(3):925-44 [PMID: 21841288]
  31. Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):55-77 [PMID: 23293271]
  32. Gut. 2007 Nov;56(11):1585-9 [PMID: 17591622]
  33. N Engl J Med. 2013 Sep 19;369(12):1095-105 [PMID: 24047059]
  34. Gut. 2012 Oct;61(10):1439-46 [PMID: 22156981]
  35. Health Aff (Millwood). 2012 Dec;31(12):2747-54 [PMID: 23213159]
  36. J Med Screen. 2014 Sep;21(3):144-50 [PMID: 25070434]
  37. Gut. 2015 Aug;64(8):1257-67 [PMID: 25193802]
  38. Gastroenterology. 2014 Mar;146(3):709-17 [PMID: 24012982]
  39. Eur J Cancer Prev. 2015 Jul;24(4):305-12 [PMID: 25304027]
  40. Lancet. 2010 May 8;375(9726):1624-33 [PMID: 20430429]
  41. Ann Oncol. 2010 May;21 Suppl 3:iii43-51 [PMID: 20427360]
  42. Radiology. 2008 Sep;248(3):717-20 [PMID: 18710970]

MeSH Term

Colorectal Neoplasms
Community-Institutional Relations
Female
Humans
Male
Mass Screening
Middle Aged
Multivariate Analysis
Neoplasms
Predictive Value of Tests
Referral and Consultation

Word Cloud

Created with Highcharts 10.0.0screening1CRCinreachapproachessubjectsapproachrate0PPV95%useservicesparticipatedcanceroutreach0%CIOutreachieinviteoutcomesequivalentfecal5%2010-2013twoincreased9%positivity780perioddetected8intervaldetectionintegrationBACKGROUND:existingpopulationalreadyaccessedmedicalsystemmayinfluencepeopleincreasetesthoweverwhetherremainsunclearMETHODS:total336389650-69yearsagecolorectalprogramusingbiennialimmunochemicaltests342004-2009aloneused65integratedcompareddeliveryRESULTS:Coveragerates214%364referralconfirmatorydiagnosticexaminationsdeclined533%first20%screenedpositivepredictivevalue61%second34%adjustingconfoundersdifferencesobservedadjustedrelativerisk50confidence[CI]41-1602013-1277265-0focusedcomparisonstudytesting2%vs6%remainedhigher0701-112recruitedCONCLUSIONS:OutcomesbetterIMPACT:resultswillencouragemakershealth-carepolicyadoptdeliverInreachOrganizedServiceScreeningProgramsColorectalCancer

Similar Articles

Cited By